Meridian Bioscience

Meridian Bioscience

Markets and distributes a broad range of innovative diagnostic test kits, rare reagents, specialty biologicals and components.

Launch date
Employees
Market cap
AUD2.3b
Enterprise valuation
AUD2.2b (Public information from Feb 2023)
Cincinnati Ohio (HQ)
  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO

$5.5m

Grant

$2.5m

Grant
Total FundingAUD12.4m

Recent News about Meridian Bioscience

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Meridian Bioscience

Edit
Magellan Diagnostics
ACQUISITION by Meridian Bioscience Mar 2016
Bioline
ACQUISITION by Meridian Bioscience Jul 2010
Exalenz Bioscience
ACQUISITION by Meridian Bioscience Feb 2020
SD BIOSENSOR
ACQUISITION by Meridian Bioscience Jul 2022
BreathTek
ACQUISITION by Meridian Bioscience Jul 2021